Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechSemiconductorsAdvanced MaterialsMedTech
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
M Ventures is the strategic CVC of Merck KGaA (the German Merck, not the US pharmaceutical company), founded in 2009 with a €600M+ fund allocation. The firm has made 195 investments and developed 80+ companies from creation to exit.
The dual focus spans biotechnology (healthcare, life science tools) and technology (semiconductors, display). Portfolio companies include Tignis (AI for semiconductor...
Notable Investments
T
TignisM
MemryXSimilar Funds
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A
MPM Capital
Boston, United States
DeepTech NativeBiotechMedTechSeedSeries A
Pontifax
Herzliya, Israel
DeepTech NativeBiotechMedTechSeedSeries A
Sofinnova Partners
Paris, France
DeepTech NativeBiotechMedTechClimate TechSeedSeries A